In Silico Analysis of Enantioselective Binding of Pomalidomide Targets for Multiple Myeloma
{{output}}
Pomalidomide is a 2nd-generation chiral immunomodulatory (IMiDs) drugs and have antiangiogenic activity. Despite being teratogenic, it has been shown to be effective in treating multiple myeloma. Enantioselectivity, chemical structure, and biological activity ... ...